Journal Information
Most often read
20531
Clinical Characteristics and 2-Year Outcomes of Chronic Obstructive Pulmonary Disease Patients With High Blood Eosinophil Counts: A Population-based Prospective Cohort Study in ChinaXiaohui Wu, Zhishan Deng, Fan Wu, Youlan Zheng, Peiyu Huang, Huajing Yang, Ningning Zhao, Cuiqiong Dai, ... Yumin Zhou
Arch Bronconeumol. 2024;60:402-9
20531
![](https://static.elsevier.es/multimedia/03002896/0000006000000007/v1_202407021853/S0300289624001078/v1_202407021853/en/main.assets/fx1.jpeg)
15883
Hypersensitivity Pneumonitis-like Histological Findings Secondary to SARS-COV-2 PneumoniaCristina Aljama, María Florencia Pilia, Iñigo Ojanguren
Arch Bronconeumol. 2024;60:435-6
15883
14170
Determinants of COVID-19 Hospitalization Costs in a Referral Hospital for Respiratory DiseasesDavid Martínez-Briseño, Rosario Fernández-Plata, Rogelio Pérez-Padilla, Anjarath Higuera-Iglesias, Manuel Castillejos-López, Guillermo Casas-Medina, Patricia Sierra-Vargas, Víctor Hugo Ahumada-Topete
Arch Bronconeumol. 2024;60:246-9
14170
13391
Multidisciplinary Consensus on the Management of Non-Invasive Respiratory Support in the COVID-19 PatientManel Luján, César Cinesi Gómez, Oscar Peñuelas, Carlos Ferrando, Sarah Béatrice Heili-Frades, José Manuel Carratalá Perales, Arantxa Mas, Javier Sayas Catalán, ... Carlos Egea Santaolalla
Arch Bronconeumol. 2024;60:285-95
13391
12486
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular DiseaseJavier de Miguel-Díez, Julio Núñez Villota, Salud Santos Pérez, Nicolás Manito Lorite, Bernardino Alcázar Navarrete, Juan Francisco Delgado Jiménez, Juan José Soler-Cataluña, Domingo Pascual Figal, ... Juan José Gómez Doblas
Arch Bronconeumol. 2024;60:226-37
12486
Full text access
Open Article
10321
Potential Benefits of a Cardiovascular Polypill in Long COVID PatientsJoan B. Soriano
Arch Bronconeumol. 2024;60:263-4
10321
10241
Persistent Pulmonary Fibrotic Sequelae in Patients With Telomere Shortening One Year After Severe COVID-19Alba Mulet, Pilar González-Cabo, Federico V. Pallardó, Jaime Signes-Costa
Arch Bronconeumol. 2024;60:62-4
10241
8468
Erratum to “Iatrogenic Adrenal Insufficiency Following Post COVID-19 Organizing Pneumonia” [Archivos de Bronconeumologia 59 (2023) 63–65]Esther Palones, Elena Curto, Anna Pelegrí, Marina Arilla, Ingrid Solanes, Astrid Crespo-Lessmann
Arch Bronconeumol. 2024;60:69
8468
6954
The Influence of Lung Function and Respiratory Muscle Strength on Quadriceps Muscle Fatigability in COPD Patients Under Long-term Oxygen TherapyMara Paneroni, Alessandro Cavicchia, Salvi Beatrice, Laura Bertacchini, Massimo Venturelli, Michele Vitacca
Arch Bronconeumol. 2024;60:410-6
6954
Highlights
- •
Factors that influence muscle fatigability (MF) after exercise in COPD were studied.
- •
COPD patients with very severe (VSO) and severe lung obstruction (SO) were compared.
- •
VSO patients experience lower MF (less reduction in MVC) compared to SO.
- •
Dyspnea is higher in the VSO group at the beginning and end of the exercise.
![](https://static.elsevier.es/multimedia/03002896/0000006000000007/v1_202407021853/S030028962400111X/v1_202407021853/en/main.assets/fx1.jpeg)
4335
Triple Therapy and Clinical Control in B+ COPD Patients: A Pragmatic, Prospective, Randomized TrialAlvar Agusti, José Luis Lopez-Campos, Marc Miravitlles, Juan Jose Soler-Cataluña, Jose Maria Marin, Borja G. Cosio, Bernardino Alcázar-Navarrete, Jose Maria Echave-Sustaeta, ... Bartolome R. Celli
Arch Bronconeumol. 2024;60:417-22
4335
![](https://static.elsevier.es/multimedia/03002896/0000006000000007/v1_202407021853/S0300289624001169/v1_202407021853/en/main.assets/fx1.jpeg)
4052
Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials?David Montani, Athénaïs Boucly, Olivier Sitbon
Arch Bronconeumol. 2024;60:395-6
4052
4010
Local Anesthetic Thoracoscopy: A Focus on Indications, Techniques and ComplicationsMichele Piazzolla, Cosimo C. De Pace, José M. Porcel, Pasquale Tondo
Arch Bronconeumol. 2024;60:423-30
4010
3764
CRISPR Technology in Lung Diseases: The Example of Lung Cancer and Cystic FibrosisJosé M. Porcel, Mariona Pont, Anabel Sorolla
Arch Bronconeumol. 2024;60:397-9
3764
3657
Is Cardiopulmonary Exercise Test Really Representative of Pulmonary Arterial Hypertension Patients’ Quality of Life?Tommaso Recchioni, Giovanna Manzi, Alexandra Mihai, Carmine Dario Vizza
Arch Bronconeumol. 2024;60:458-9
3657
3654
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease: Response to Additional ConsiderationsJavier de Miguel-Díez, Juan José Gómez Doblas
Arch Bronconeumol. 2024;60:392-3
3654
3238
REGINHA—Ibero-American Registry of Hypersensitivity PneumonitisMaría Laura Alberti, Emily Rincón Álvarez, Vanesa Vicens-Zygmunt
Arch Bronconeumol. 2024;60:400-1
3238
3156
Mortality Risk in BronchiectasisDiego J. Maselli, Alejandro A. Diaz
Arch Bronconeumol. 2024;60:333-5
3156
2370
High-flow Nasal Cannula Ventilatory ModalitiesSalvador Díaz Lobato, José Manuel Carratalá Perales, Guillermo Montiel, José Miguel Alonso Íñigo
Arch Bronconeumol. 2024;60:122-3
2370